Log in

CVE:MED - Medgold Resources Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: C$0.06
52-Week Range N/A
Volume52,500 shs
Average Volume46,450 shs
Market CapitalizationC$5.69 million
P/E RatioN/A
Dividend YieldN/A
Medgold Resources Corp., an exploration stage company, engages in the acquisition and exploration of resource properties primarily in Serbia. It explores for gold, silver, and precious and base metals. The company holds 100% interest in the Tlamino project that comprises a block of two contiguous claims, including Donje Tlamino and Surlica-Ducat totaling 192 square kilometers; and five granted exploration licenses covering an area of approximately 570 square kilometers located in the Serbo-Macedonian Massif belt, Serbia. Medgold Resources Corp. is headquartered in Vancouver, Canada.

Industry, Sector and Symbol

Industry Industrial Metals & Minerals
SectorBasic Materials



Sales & Book Value

Annual SalesN/A
Book ValueC$0.01 per share



Market CapC$5.69 million
Next Earnings Date5/4/2020 (Estimated)

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

Medgold Resources (CVE:MED) Frequently Asked Questions

What is Medgold Resources' stock symbol?

Medgold Resources trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MED."

When is Medgold Resources' next earnings date?

Medgold Resources is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Medgold Resources.

Has Medgold Resources been receiving favorable news coverage?

Media headlines about MED stock have been trending negative recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Medgold Resources earned a news sentiment score of -2.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Medgold Resources.

Who are some of Medgold Resources' key competitors?

What other stocks do shareholders of Medgold Resources own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medgold Resources investors own include Nevsun Resources (NSU) and Cannabis Technologies (IN).

Who are Medgold Resources' key executives?

Medgold Resources' management team includes the folowing people:
  • Mr. Simon T. P. Ridgway, Exec. Chairman (Age 70)
  • Mr. Kevin Bales, Chief Financial Officer (Age 52)
  • Mr. Jeremy Crozier, Pres, CEO & Director
  • Mr. Brent Cook BSc (Geology), Technical Advisor

How do I buy shares of Medgold Resources?

Shares of MED and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How big of a company is Medgold Resources?

Medgold Resources has a market capitalization of C$0.00. View Additional Information About Medgold Resources.

What is Medgold Resources' official website?

The official website for Medgold Resources is http://www.medgoldresources.com/.

How can I contact Medgold Resources?

Medgold Resources' mailing address is 200 Burrard St Suite 650, VANCOUVER, BC V6C 3L6, Canada. The company can be reached via phone at +1-604-8015432.

MarketBeat Community Rating for Medgold Resources (CVE MED)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  91
MarketBeat's community ratings are surveys of what our community members think about Medgold Resources and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel